Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Stephan Reichl, Christian Kölln, Matthias Hahne & Jessica Verstraelen. (2011)
In vitro cell culture models to study the corneal drug absorption. Expert Opinion on Drug Metabolism & Toxicology 7:5, pages 559-578.
Read now
Read now
Tetsuya Tajika, Hiroaki Takahashi, Yusuke Sakai, Hiroyuki Fujii, Akiharu Isowaki & Hideyuki Sakaki. (2010) Metabolic profiles of difluprednate in rabbit ocular tissues after instillation of difluprednate ophthalmic emulsion. Xenobiotica 40:8, pages 569-577.
Read now
Read now
Mayssa Attar, Jie Shen, Kah-Hiing John Ling & Diane Tang-Liu. (2005) Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters. Expert Opinion on Drug Delivery 2:5, pages 891-908.
Read now
Read now
Sreeraj Macha, Sridhar Duvvuri & Ashim K. Mitra. (2004) Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis. Current Eye Research 28:2, pages 77-84.
Read now
Read now
Franz-Josef Leinweber. (1991) Drug Disposition in the Mammalian Eye and Brain: A Comparison of Mechanisms. Drug Metabolism Reviews 23:1-2, pages 133-246.
Read now
Read now
Wei Wang, Hans Bundgaard, Anders Buur & Vincent H.L. Lee. (1991) Corneal penetration of 5-fluorouracil and its improvement by prodrug derivatization in the albino rabbit: implication in glaucoma filtration surgery. Current Eye Research 10:1, pages 87-97.
Read now
Read now
Articles from other publishers (33)
James E. Chastain. 2022. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics
179
219
.
Donald J. AbrahamPaul W. Erhardt, Rahul Khupse, Jeffrey G. Sarver & Brian J. Kress. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
105
.
Anam Hammid, John K. Fallon, Toni Lassila, Giulia Salluce, Philip C. Smith, Ari Tolonen, Achim Sauer, Arto Urtti & Paavo Honkakoski. (2021) Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues. Molecular Pharmaceutics 18:3, pages 1305-1316.
Crossref
Crossref
Sanjeev Kumar Paikra, Janmejaya Bag & Monalisa Mishra. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
259
283
.
Emma M. Heikkinen, Eva M. del Amo, Veli-Pekka Ranta, Arto Urtti, Kati-Sisko Vellonen & Marika Ruponen. (2018) Esterase activity in porcine and albino rabbit ocular tissues. European Journal of Pharmaceutical Sciences 123, pages 106-110.
Crossref
Crossref
Yong Chen & Yogeshvar N. Kalia. (2018) Short-duration ocular iontophoresis of ionizable aciclovir prodrugs: A new approach to treat herpes simplex infections in the anterior and posterior segments of the eye. International Journal of Pharmaceutics 536:1, pages 292-300.
Crossref
Crossref
Verena Santer, Sergio del Río Sancho, Maria Lapteva & Yogeshvar N. Kalia. (2017) Targeted intracorneal delivery—Biodistribution of triamcinolone acetonide following topical iontophoresis of cationic amino acid ester prodrugs. International Journal of Pharmaceutics 525:1, pages 43-53.
Crossref
Crossref
Marta Rodriguez-Aller, Davy Guillarme, Mohamed El Sanharawi, Francine Behar-Cohen, Jean-Luc Veuthey & Robert Gurny. (2013) In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application. Journal of Controlled Release 170:1, pages 153-159.
Crossref
Crossref
Nello Mainolfi, James Powers, Jakal Amin, Debby Long, Wendy Lee, Margaret E. McLaughlin, Bruce Jaffee, Christopher Brain, Jason Elliott & Jeremy M. Sivak. (2013)
An Effective Prodrug Strategy to Selectively Enhance Ocular Exposure of a Cannabinoid Receptor (CB
1/2
) Agonist
. Journal of Medicinal Chemistry 56:13, pages 5464-5472.
Crossref
Crossref
Philippe DaullChristopher A. PatersonBaruch D. KuppermannJean-Sébastien Garrigue. (2013) A Preliminary Evaluation of Dexamethasone Palmitate Emulsion: A Novel Intravitreal Sustained Delivery of Corticosteroid for Treatment of Macular Edema. Journal of Ocular Pharmacology and Therapeutics 29:2, pages 258-269.
Crossref
Crossref
Megha Barot, Mitesh Patel, Deep Kwatra & Ashim K. Mitra. 2013. Ocular Transporters and Receptors. Ocular Transporters and Receptors
229
248
.
Chandrasena R. Pamulapati & Ronald D. Schoenwald. (2011) Ocular Pharmacokinetics of a Novel Tetrahydroquinoline Analog in Rabbit: Absorption, Disposition, and Non-compartmental Analysis. Journal of Pharmaceutical Sciences 100:12, pages 5315-5323.
Crossref
Crossref
Adriana L. Andrade, Kenneth Melich, G. Gregory Whatley, Sarah R. Kirk & Jeffrey W. Karpen. (2011) Cyclic Nucleotide-Gated Channel Block by Hydrolysis-Resistant Tetracaine Derivatives. Journal of Medicinal Chemistry 54:13, pages 4904-4912.
Crossref
Crossref
Donald J. AbrahamPaul W. Erhardt, Rahul Khupse, Jeffrey G. Sarver & Jill A. Trendel. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
219
288
.
Suresh Katragadda, Sriram Gunda, Sudharshan Hariharan & Ashim K. Mitra. (2008) Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: Evaluation of their utility in treating ocular HSV infections. International Journal of Pharmaceutics 359:1-2, pages 15-24.
Crossref
Crossref
Mayssa Attar & Jie Shen. 2008. Ocular Transporters In Ophthalmic Diseases And Drug Delivery. Ocular Transporters In Ophthalmic Diseases And Drug Delivery
375
397
.
G. Cavallaro, L. Maniscalco, G. Giammona, C. Civiale, M.G. Mazzone & V. Enea. (2004) Chemical conjugation of dexamethasone to a polyaspartamide and in vitro evaluation studies. Journal of Drug Delivery Science and Technology 14:5, pages 373-381.
Crossref
Crossref
Ronald Schoenwald. 2003. Ophthalmic Drug Delivery Systems, Second Edition. Ophthalmic Drug Delivery Systems, Second Edition
135
179
.
James Chastain. 2003. Ophthalmic Drug Delivery Systems, Second Edition. Ophthalmic Drug Delivery Systems, Second Edition
59
107
.
Giridhar S. Tirucherai, Clapton Dias & Ashim K. Mitra. (2002) Corneal Permeation of Ganciclovir: Mechanism of Ganciclovir Permeation Enhancement by Acyl Ester Prodrug Design. Journal of Ocular Pharmacology and Therapeutics 18:6, pages 535-548.
Crossref
Crossref
Sreeraj Macha & Ashim K. Mitra. (2002) Ocular Disposition of Ganciclovir and Its Monoester Prodrugs following Intravitreal Administration Using Microdialysis. Drug Metabolism and Disposition 30:6, pages 670-675.
Crossref
Crossref
Clapton S. Dias, Banmeet S. Anand & Ashim K. Mitra. (2002) Effect of Mono‐ and Di‐acylation on the Ocular Disposition of Ganciclovir: Physicochemical Properties, Ocular Bioreversion, and Antiviral Activity of Short Chain Ester Prodrugs. Journal of Pharmaceutical Sciences 91:3, pages 660-668.
Crossref
Crossref
C. Geraldine M. Jordan. (1998) How an Increase in the Carbon Chain Length of the Ester Moiety Affects the Stability of a Homologous Series of Oxprenolol Esters in the Presence of Biological Enzymes. Journal of Pharmaceutical Sciences 87:7, pages 880-885.
Crossref
Crossref
Ronald D. Schoenwald, Veneeta Tandon, Dale Eric Wurster & Charles F. Barfknecht. (1998) Significance of melanin binding and metabolism in the activity of 5-acetoxyacetylimino-4-methyl-Δ2-1,3,4,-thiadiazoline-2-sulfonamide1This paper represents a partial fulfillment of Ph.D. degree requirements (V. Tandon) and does not represent either information or contribution of any kind from the FDA.1. European Journal of Pharmaceutics and Biopharmaceutics 46:1, pages 39-50.
Crossref
Crossref
Vincent Baeyens & Robert Gurny. (1997) Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. Pharmaceutica Acta Helvetiae 72:4, pages 191-202.
Crossref
Crossref
C. Geraldine, M. Jordan, Gordon W. Davis & Richard F. Timoney. (1996) Studies showing the effect of enzymes on the stability of ester prodrugs of propranolol and oxprenolol in biological samples. International Journal of Pharmaceutics 141:1-2, pages 125-135.
Crossref
Crossref
Tomi Järvinen & Kristiina Järvinen. (1996) Prodrugs for improved ocular drug delivery. Advanced Drug Delivery Reviews 19:2, pages 203-224.
Crossref
Crossref
Tomi Järvinen, Minna Poikolainen, Pekka Suhonen, Jouko Vepsäläinen, Sakari Alaranta & Arto Urtti. (1995) Comparison of Enzymatic Hydrolysis of Pilocarpine Prodrugs in Human Plasma, Rabbit Cornea, and Butyrylcholinesterase Solutions. Journal of Pharmaceutical Sciences 84:5, pages 656-660.
Crossref
Crossref
DER-YANG LEE, RONALD D. SCHOENWALD & CHARLES F. BARFKNECHT. (1992) Biopharmaceutical Explanation for the Topical Activity of 6-Hydroxyethoxy-2-Benzothiazolesulfonamide in the Rabbit Eye. Journal of Ocular Pharmacology and Therapeutics 8:3, pages 247-265.
Crossref
Crossref
Vincent H.L Lee & Vincent H.K Li. (1989) Prodrugs for improved ocular drug delivery. Advanced Drug Delivery Reviews 3:1, pages 1-38.
Crossref
Crossref
Hans Bundgaard, Anders Buur, Shih-Chieh Chang & Vincent H.L. Lee. (1986) Prodrugs of timolol for improved ocular delivery: synthesis, hydrolysis kinetics and lipophilicity of various timolol esters. International Journal of Pharmaceutics 33:1-3, pages 15-26.
Crossref
Crossref
Hans Bundgaard, Erik Falch, Claus Larsen, Gerold L. Mosher & Thomas J. Mikkelson. (1986) Pilocarpine Prodrugs II. Synthesis, Stability, Bioconversion, and Physicochemical Properties of Sequentially Labile Pilocarpine Acid Diesters. Journal of Pharmaceutical Sciences 75:8, pages 775-783.
Crossref
Crossref
VINCENT H.L. LEE & JOSEPH R. ROBINSON. (1986) Topical Ocular Drug Delivery: Recent Developments and Future Challenges. Journal of Ocular Pharmacology and Therapeutics 2:1, pages 67-108.
Crossref
Crossref